The ketogenic diet inhibits the mammalian target of rapamycin (mTOR) pathway.
about
The ketogenic diet as a treatment paradigm for diverse neurological disordersKetogenic diet in neuromuscular and neurodegenerative diseasesOptimal management of seizures associated with tuberous sclerosis complex: current and emerging optionsKetogenic diet for obesity: friend or foe?Role of β-hydroxybutyrate, its polymer poly-β-hydroxybutyrate and inorganic polyphosphate in mammalian health and diseaseHarnessing the power of metabolism for seizure prevention: focus on dietary treatmentsMapping the spatio-temporal pattern of the mammalian target of rapamycin (mTOR) activation in temporal lobe epilepsyCaloric restriction protects against electrical kindling of the amygdala by inhibiting the mTOR signaling pathway.Tumor Cells Growth and Survival Time with the Ketogenic Diet in Animal Models: A Systematic ReviewKetone bodies as signaling metabolites.Beyond weight loss: a review of the therapeutic uses of very-low-carbohydrate (ketogenic) diets.The mTOR inhibitor rapamycin has limited acute anticonvulsant effects in mice.Potential therapeutic use of the ketogenic diet in autism spectrum disordersKetogenic diets: from cancer to mitochondrial diseases and beyond.Therapeutic role of mammalian target of rapamycin (mTOR) inhibition in preventing epileptogenesis.MTO1 mediates tissue specificity of OXPHOS defects via tRNA modification and translation optimization, which can be bypassed by dietary intervention.β-hydroxybutyrate: much more than a metaboliteKetogenic diet in a patient with congenital hyperinsulinism: a novel approach to prevent brain damageKetogenic diets, mitochondria, and neurological diseases.Glycemic modulation in neuro-oncology: experience and future directions using a modified Atkins diet for high-grade brain tumors.The ketogenic diet: metabolic influences on brain excitability and epilepsy.Mammalian target of rapamycin (mTOR) inhibition: potential for antiseizure, antiepileptogenic, and epileptostatic therapy.Everolimus is better than rapamycin in attenuating neuroinflammation in kainic acid-induced seizures.Metabolic Dysfunction Underlying Autism Spectrum Disorder and Potential Treatment Approaches.Calories, carbohydrates, and cancer therapy with radiation: exploiting the five R's through dietary manipulation.Hypothalamic hormones and metabolism.Ketogenic diets: new advances for metabolism-based therapies.The mTOR signaling pathway in the brain: focus on epilepsy and epileptogenesis.Autophagy and amino acid metabolism in the brain: implications for epilepsy.mTOR inhibition in epilepsy: rationale and clinical perspectives.A bioenergetics systems evaluation of ketogenic diet liver effects.How does the ketogenic diet work? Four potential mechanismsKetogenesis contributes to intestinal cell differentiation.The Role of mTOR Inhibitors in the Treatment of Patients with Tuberous Sclerosis Complex: Evidence-based and Expert Opinions.Ketogenic Diet and Cancer-a Perspective.Ketogenic diet for epilepsy treatment.Tuberous sclerosis complex: From molecular biology to novel therapeutic approaches.Novel therapeutic approaches for disease-modification of epileptogenesis for curing epilepsy.DEPDC5 as a potential therapeutic target for epilepsy.Ketogenic Diet for the Management of Epilepsy Associated with Tuberous Sclerosis Complex in Children
P2860
Q21129287-7B956ABD-7087-4321-BB89-CA0831927B43Q21284703-1EB2FDA0-5424-40D7-A539-C0E851DE35BFQ22305852-13FCA8F4-37E1-4B78-A781-EC00E0C6D631Q26824104-2B587F51-0F28-45C9-B93A-C33F10DF16BBQ26828498-E66577FC-4AE5-4042-8797-5818BA6FB810Q26991869-67C58F8D-0469-4A01-87EF-A6E3F99DD4BCQ28480776-0A55561B-17BB-4063-B2A6-E0A8D3A23BACQ30626751-28579261-08DC-4046-B35D-813A2CB23B9FQ33743850-6172545E-4A6C-43DC-9E9A-8F473E980EBDQ34252732-44BDC059-808F-4C8B-82F8-11F7AE1B774EQ34353543-8685BD7D-5B45-4C51-B359-B9CC0448830DQ34416405-3169BCD0-580F-46A3-B558-488FD97B33B3Q34431317-5CE50856-C383-4864-ABB6-00FF5CE36899Q34509699-F72BE205-AA0C-45FC-8097-EAC228F0B8AFQ35028378-9308302D-4A33-4084-BCB2-8418E4B99486Q35234097-3A38D1A0-26A0-4048-9BDA-0BE8579092B0Q35553084-5501A6ED-0487-4A67-AFFA-68B113B85501Q36087987-D51C68FC-5D5D-452E-AAA6-D8030A247150Q36196765-9A0B159A-DFC7-4B5D-BE8E-B418B097D238Q36351072-36704D4E-6CB9-4BB3-A345-C80FA43C28F0Q36501202-961E8AEC-F195-4D74-A12C-960D5D72048AQ37419781-E6CC5723-9D70-498F-BCD3-901DA7224DBEQ37597272-FE2E5166-F14F-4F11-AEC0-EB0337F56AA8Q37653680-2ABAF1B9-B83E-4387-A7E1-36B64BDECB74Q37705691-33E958AE-D2D8-44E0-A6C0-005861410F53Q37920318-89D1CDAA-BDCD-4F4C-AC7B-CC582AFE0E2EQ37982950-ACD915B0-BFE9-4365-8DEE-489F51C4F401Q38028872-72E79F30-67F0-4399-A572-8B6AEFE44896Q38242039-C51FC237-AEFF-49E6-814A-1E10F9DEBD93Q38336887-30469A5A-25EB-4D38-898C-9AD4CA1CA33EQ38370749-79F9D361-2378-4353-80E1-3DD9C7AB8C95Q38582924-CAC02BDE-D113-4835-B6F5-CB2732A9F24FQ38726932-C25A46D3-B9DB-49C1-9182-E80E6B7AE34CQ38755497-0BAFB082-9EF9-4F16-A060-6FB13B8EEC75Q38936285-4FE86C58-B39B-4E1B-B68D-8445C7D586BEQ38985397-723055A7-DAE8-4D4A-83B0-CE2C26E14244Q38994919-B4101939-FA2C-415B-99DE-286F1F36CBA6Q39126886-3D4B7964-DCA4-45ED-8BB5-6B0F13FE31C4Q39239920-D40F8902-E064-4B22-932E-94F8B28D461EQ41218069-79F39547-945E-4CF4-800A-489C1F567DCA
P2860
The ketogenic diet inhibits the mammalian target of rapamycin (mTOR) pathway.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
The ketogenic diet inhibits the mammalian target of rapamycin (mTOR) pathway.
@en
The ketogenic diet inhibits the mammalian target of rapamycin
@nl
type
label
The ketogenic diet inhibits the mammalian target of rapamycin (mTOR) pathway.
@en
The ketogenic diet inhibits the mammalian target of rapamycin
@nl
prefLabel
The ketogenic diet inhibits the mammalian target of rapamycin (mTOR) pathway.
@en
The ketogenic diet inhibits the mammalian target of rapamycin
@nl
P2093
P2860
P1433
P1476
The ketogenic diet inhibits the mammalian target of rapamycin (mTOR) pathway.
@en
P2093
Kelvin A Yamada
Liu Lin Thio
Michael Wong
Nicholas R Rensing
Sharon S McDaniel
P2860
P356
10.1111/J.1528-1167.2011.02981.X
P577
2011-03-03T00:00:00Z